Allogene Therapeutics, Inc. (ALLO) Tops Q4 EPS by 6c

Allogene Therapeutics, Inc. (NASDAQ: ALLO) reported Q4 EPS of ($0.17), $0.06 better than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Allogene Therapeutics, Inc. (ALLO) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• TOP Financial Group offers 6.4 million shares at $0.45645 each
• William Blair Upgrades Backblaze Inc (BLZE) to Market Perform